Cite
MLA Citation
R Rocconi et al.. “15 Randomized double-blind placebo controlled trial of frontline maintenance vigil immunotherapy (VITAL study) in stage III/IV ovarian cancer: efficacy assessment in BRCA1/2-wt patients.” International journal of gynecological cancer, vol. 30, n.d., pp. A11–A12. http://access.bl.uk/ark:/81055/vdc_100144730263.0x00001f